{"name": "Genmab",
 "permalink": "genmab",
 "crunchbase_url": "http://www.crunchbase.com/company/genmab",
 "homepage_url": "http://www.genmab.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@genmab.com",
 "phone_number": "+ 45 7020 2728",
 "description": "",
 "created_at": "Wed Oct 28 07:29:22 UTC 2009",
 "updated_at": "Fri Jul 02 02:03:03 UTC 2010",
 "overview": "\u003Cp\u003EGenmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Genmab\u0026#8217;s world class discovery, development and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs. Our primary goal is to improve the lives of patients who are in urgent need of new treatment options.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0006/3972/63972v1-max-150x150.png"],
     [[250,
       73],
      "assets/images/resized/0006/3972/63972v1-max-250x250.png"],
     [[265,
       78],
      "assets/images/resized/0006/3972/63972v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Co-Founder",
    "person":
     {"first_name": "Dr.",
      "last_name": "Donald Drakeman",
      "permalink": "dr-donald-drakeman",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$157M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/genmab-wins-23m-blockbuster-cancer-approval/2009-10-27?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Genmab wins $23M on blockbuster cancer approval",
    "raised_amount": 23000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 10,
    "funded_day": 1,
    "investments":
     [{"company":
        {"name": "GlaxoSmithKline",
         "permalink": "glaxosmithkline",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0005/1020/51020v1-max-150x150.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-250x250.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/genmab-grabs-134m-it-restructures-blockbuster-gsk-pact/2010-07-01?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Genmab grabs $134M as it restructures blockbuster GSK pact  Read more: Genmab grabs $134M as it restructures blockbuster GSK pact",
    "raised_amount": 134000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 1,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Bredgade 34",
    "address2": "",
    "zip_code": "1260",
    "city": "Copenhagen K ",
    "state_code": null,
    "country_code": "DNK",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}